Rate Professor Graham Mann

Professional Summary: Professor Graham Mann

Professor Graham Mann is a distinguished academic and researcher affiliated with the University of Sydney, Australia. With a career spanning decades, he is recognized for his contributions to medical research, particularly in the field of melanoma and cancer genetics. Below is a detailed overview of his academic journey, research focus, and professional achievements based on publicly available information.

Academic Background and Degrees

Professor Mann holds advanced degrees in medicine and science, reflecting his deep expertise in clinical and research domains. Specific details of his educational background include:

• Bachelor of Medicine and Bachelor of Surgery (MBBS) from an Australian institution (exact institution and year not publicly specified in accessible sources).
• PhD in a field related to cancer research or genetics (specific focus and conferring institution not fully detailed in public records but aligned with his later work).

Research Specializations and Academic Interests

Professor Mann’s research primarily focuses on melanoma, a critical area of cancer research. His work explores the genetic and environmental factors contributing to melanoma risk, as well as strategies for prevention and treatment. Key areas of interest include:

• Cancer genetics and genomics, particularly in melanoma.
• Epidemiology of skin cancer and risk assessment.
• Development of personalized medicine approaches for cancer treatment.

Career History and Appointments

Professor Mann has held significant academic and research positions, contributing to both the University of Sydney and broader medical research communities. His career highlights include:

• Professor at the University of Sydney, associated with the Sydney Medical School.
• Co-Director of the Centre for Cancer Research at the Westmead Institute for Medical Research, where he has led initiatives in melanoma research.
• Key researcher in collaborative projects such as the Australian Melanoma Genome Project.

Major Awards, Fellowships, and Honors

While specific awards and honors are not exhaustively listed in public sources, Professor Mann’s leadership in melanoma research suggests recognition within the scientific community. Notable mentions include:

• Recognition for contributions to cancer research through collaborative projects and publications.
• Potential fellowships or grants from organizations like the National Health and Medical Research Council (NHMRC) of Australia (specific details not publicly confirmed in accessible records).

Key Publications

Professor Mann has authored and co-authored numerous high-impact publications in the field of melanoma and cancer genetics. A selection of notable works includes:

• ‘Genome-wide association study identifies three new melanoma susceptibility loci’ (2011), published in Nature Genetics.
• ‘A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma’ (2011), published in Nature.
• Contributions to multiple papers on melanoma risk factors and genetic profiling in journals such as The Lancet Oncology and Journal of Clinical Oncology (specific titles and years vary across his extensive bibliography).

Influence and Impact on Academic Field

Professor Mann’s research has significantly advanced the understanding of melanoma at a genetic level, influencing both clinical practices and public health strategies for skin cancer prevention in Australia and beyond. His work on identifying genetic risk factors has paved the way for targeted therapies and personalized treatment plans, contributing to global efforts in reducing melanoma mortality rates. His leadership in large-scale genomic projects has also fostered international collaboration in cancer research.

Public Lectures, Committee Roles, and Editorial Contributions

While specific details of public lectures or editorial roles are not widely documented in accessible public sources, Professor Mann’s prominence suggests involvement in the following:

• Presentations at international conferences on cancer research and melanoma.
• Potential membership in advisory committees or panels related to cancer research funding or policy in Australia (exact roles not confirmed in public data).
• Contributions as a peer reviewer or editorial board member for scientific journals in oncology and genetics (specific journals not listed in available records).